RECURRENT GLIOMA
Clinical trials for RECURRENT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug help fight aggressive brain tumors?
Disease control Not yet recruitingThis early-phase trial tests sitagliptin, a diabetes medicine, combined with standard bevacizumab in 45 adults with recurrent grade 4 glioma (a fast-growing brain cancer). The goal is to find the safest dose and see if the combination can reduce certain immune cells that may help…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Kailin Yang, MD, PhD • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New PET tracer aims to spot brain tumors vs. radiation damage
Diagnosis Not yet recruitingThis early-phase study tests a new radioactive imaging agent called MeFAMP to see if it can safely and accurately detect brain tumors using PET scans. The study includes healthy volunteers and people with recurrent brain tumors or tumors that spread from other cancers. The goal i…
Matched conditions: RECURRENT GLIOMA
Phase: EARLY_PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated May 14, 2026 12:06 UTC